Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac Sodium for Preventing Macular Edema After Cataract Surgery
NCT07749027Completed
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Trial of nepafenac in macular edema (2 arms). Primary endpoint: Central macular thickness at 60 days. Started Jan 2026; status: completed.
02
Drugs
nepafenac
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT07749027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07749027.